TAK
TAKEDA PHARMACEUTICAL CO LTDHealthcare · Drug Manufacturers - Specialty & Generic
$235.97 sample
+2.70 (+1.16%) 1D
Market cap
$1.28T
Price as of
2026-10-29
Latest filing
8-K · 2026-10-14
Alerts
8
Price$235.97 +4.63% 3M daily closessample
238.88213.05
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 21INS
- Oct 14SEC
- Oct 08INS
- Oct 05SEC
- Sep 25INS
- Sep 21SEC
- Sep 11INS
- Sep 08SEC
Company facts
SEC EDGAR registration- Name
- TAKEDA PHARMACEUTICAL CO LTD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Smart-money score
- -7sample, -100 to +100
- Reporting currency
- USD
Who is positioning in TAK
sample- Insiders
- 33 insider transactions over 90 days, net selling, $32.2M
- Congress
- 4 members traded over 90 days
- Institutions · 13F
- 22 funds hold $18.1B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$81.7B +18.2% y/y
Q4 2024Q3 2026
Inventory$47.0B +14.8% y/y
Q4 2024Q3 2026
Accounts receivable$35.9B +6.0% y/y
Q4 2024Q3 2026
Total debt$99.9B +15.3% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $285.7B +10.0% 3M
- Sample peer B
- $908.2B -4.3% 3M
- Sample peer C
- $190.9B -12.7% 3M
- Sample peer D
- $842.1B +7.1% 3M
- Sample peer E
- $813.9B -7.0% 3M